Medical and Pharmaceutical
InMed Pharmaceuticals has initiated a clinical trial for its epidermolysis bullosa treatment, after regulatory approval in December
Hi, what are you looking for?
Mugglehead Investment Magazine
Health and Safety
Researchers say illicit THC products link 82 per cent of EVALI cases
CBD
The bipartisan bill would allow for hemp-derived CBD to be sold as a dietary supplement
Coming soon
Treatments for back pain and hemorrhoids will hit shelves mid-2020, company says
News
'Once you go Blk ...' recalls a saying that hypersexualizes black men, who were portrayed as weed-crazed predators at the dawn of the war...
Cannabis 2.0
The province's online retailer had 3,000 customers ready to shop when sales opened at 9 a.m.
Canada
Without representation cannabis companies will miss out on key market opportunities
Canada
Company says its quality cannabis 2.0 products will keep its revenues growing in future quarters
Canada
While industry decries the country's strict pot regulations, Edmonton city councillor Mike Nickel paves the way for Canada's first legal consumption lounges
Coming soon
Emery's new lobbying group, Fair Cannabis, calls for unison from all players big and small